Latest Insider Transactions at Agilon Health, Inc. (AGL)
This section provides a real-time view of insider transactions for Agilon Health, Inc. (AGL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of agilon health, inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of agilon health, inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 16
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Open market or private sale
|
Direct |
60,000
-17.82%
|
$1,560,000
$26.09 P/Share
|
|
Mar 16
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+15.12%
|
$180,000
$3.0 P/Share
|
|
Mar 15
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
55,000
-49.81%
|
$1,265,000
$23.81 P/Share
|
|
Mar 15
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+47.52%
|
$400,000
$4.49 P/Share
|
|
Mar 15
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
60,000
-29.11%
|
$1,380,000
$23.8 P/Share
|
|
Mar 15
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
95,000
+29.72%
|
$95,000
$1.0 P/Share
|
|
Mar 15
2023
|
John William Wulf Director |
SELL
Open market or private sale
|
Direct |
80,000
-39.33%
|
$1,840,000
$23.82 P/Share
|
|
Mar 15
2023
|
John William Wulf Director |
BUY
Exercise of conversion of derivative security
|
Direct |
80,000
+28.23%
|
$320,000
$4.5 P/Share
|
|
Mar 08
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
8,094
-43.7%
|
$194,256
$24.44 P/Share
|
|
Mar 08
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,094
+30.41%
|
$64,752
$8.99 P/Share
|
|
Mar 07
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
8,094
-43.7%
|
$194,256
$24.36 P/Share
|
|
Mar 07
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,094
+30.41%
|
$64,752
$8.99 P/Share
|
|
Feb 17
2023
|
Diana Mckenzie Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,078
+50.0%
|
-
|
|
Feb 15
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
8,094
-43.7%
|
$178,068
$22.98 P/Share
|
|
Feb 15
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,094
+30.41%
|
$64,752
$8.99 P/Share
|
|
Feb 15
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
28,555
-52.7%
|
$656,765
$23.37 P/Share
|
|
Feb 15
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
28,555
+34.51%
|
$28,555
$1.0 P/Share
|
|
Feb 14
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
25,881
-71.28%
|
$569,382
$22.99 P/Share
|
|
Feb 14
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,881
+41.62%
|
$207,048
$8.99 P/Share
|
|
Feb 14
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
50,000
-66.12%
|
$1,100,000
$22.98 P/Share
|
|
Feb 14
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+27.88%
|
$100,000
$2.0 P/Share
|
|
Feb 02
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
30,782
-74.7%
|
$677,204
$22.99 P/Share
|
|
Feb 02
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,782
+42.76%
|
$246,256
$8.99 P/Share
|
|
Feb 01
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-34.1%
|
$113,316
$21.76 P/Share
|
|
Feb 01
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+25.43%
|
$43,168
$8.99 P/Share
|
|
Jan 20
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-34.1%
|
$102,524
$19.92 P/Share
|
|
Jan 20
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+25.43%
|
$43,168
$8.99 P/Share
|
|
Jan 19
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
10,792
-50.86%
|
$205,048
$19.73 P/Share
|
|
Jan 19
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,792
+33.71%
|
$86,336
$8.99 P/Share
|
|
Jan 18
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
20,723
-44.71%
|
$393,737
$19.78 P/Share
|
|
Jan 18
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,723
+30.9%
|
$62,169
$3.0 P/Share
|
|
Jan 17
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
25,722
-50.09%
|
$488,718
$19.91 P/Share
|
|
Jan 17
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,722
+33.38%
|
$77,166
$3.0 P/Share
|
|
Jan 06
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
2,698
-20.56%
|
$40,470
$15.46 P/Share
|
|
Jan 06
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,698
+17.05%
|
$21,584
$8.99 P/Share
|
|
Jan 05
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
2,698
-20.56%
|
$40,470
$15.51 P/Share
|
|
Jan 05
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,698
+17.05%
|
$21,584
$8.99 P/Share
|
|
Dec 16
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,398
-34.11%
|
$86,368
$16.82 P/Share
|
|
Dec 16
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,398
+25.44%
|
$21,592
$4.49 P/Share
|
|
Dec 15
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,398
-34.11%
|
$91,766
$17.42 P/Share
|
|
Dec 15
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,398
+25.44%
|
$21,592
$4.49 P/Share
|
|
Dec 15
2022
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
18,750
-42.25%
|
$318,750
$17.26 P/Share
|
|
Dec 15
2022
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+29.7%
|
$56,250
$3.0 P/Share
|
|
Dec 14
2022
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
18,750
-42.25%
|
$318,750
$17.52 P/Share
|
|
Dec 14
2022
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+29.7%
|
$56,250
$3.0 P/Share
|
|
Dec 06
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,398
-34.11%
|
$91,766
$17.72 P/Share
|
|
Dec 06
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,398
+25.44%
|
$21,592
$4.49 P/Share
|
|
Dec 05
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,398
-34.11%
|
$91,766
$17.8 P/Share
|
|
Dec 05
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,398
+25.44%
|
$21,592
$4.49 P/Share
|
|
Nov 18
2022
|
Steven Sell CEO & President |
BUY
Open market or private purchase
|
Indirect |
2,900
+50.0%
|
$49,300
$17.14 P/Share
|